查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965812

氯仿市場－全球產業規模、佔有率、趨勢、機會、預測：按等級、最終用戶、地區和競爭格局分類，2021-2031年

Chloroform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Grade, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球氯仿市場預計將從 2025 年的 1,048,620 噸成長到 2031 年的 1,235,420 噸，複合年成長率為 2.77%。

氯仿（化學名稱：三氯甲烷）是一種高揮發性、高密度、無色的液態有機化合物，主要用作溶劑，也是生產含氟聚合物和冷媒的重要前驅物。市場成長主要受工業界對聚四氟乙烯（PTFE）等含氟聚合物的強勁需求驅動，這些聚合物是電子和汽車行業高性能應用的關鍵材料。此外，氯仿作為生產氟烴塑膠-22（HCFC-22）的原料，尤其是在非排放原料應用領域，其持續需求也維持了氯仿的生產水準。

市場概覽
預測期 2027-2031
市場規模：2025年 1,048,620噸
市場規模：2031年 1,235,420噸
複合年成長率：2026-2031年 2.77%
成長最快的細分市場 技術級
最大的市場 亞太地區

根據歐洲氯氣協會（EuroChlor）預測，到2024年，其成員公司的氯氣總產量將達到804.1萬噸，為包括氯仿在內的氯甲烷價值鏈提供關鍵原料。儘管上游供應穩定，但由於嚴格的環境法規以及人們對化學品潛在致癌性和毒性的健康擔憂，市場面臨巨大的障礙。這些監管限制，加上《蒙特婁議定書的逐步淘汰消耗臭氧層物質的全球義務，構成了可能限制未來市場成長的重大挑戰。

市場促進因素

全球氯仿市場的主要驅動力是含氟聚合物（尤其是聚四氟乙烯 (PTFE)）需求的不斷成長。 PTFE 的生產高度依賴氯仿作為其主要原料。氯仿具有優異的熱穩定性和耐化學性，可加工成氫氟烴塑膠-22 (HCFC-22)，這是合成高性能含氟聚合物的關鍵單體，廣泛應用於建築、電子和汽車產業。此外，轉向使用全球暖化潛值 (GWP) 更低的冷媒以及採用以氯仿衍生物為關鍵中間體的特種冷媒混合物也進一步推動了這一需求。凱莫爾公司於 2025 年 2 月發布的「2024 年第四季及全年業績報告」也印證了這一成長趨勢。該報告顯示，其熱感及特種解決方案部門 2024 年第四季的銷售量成長了 7%，主要得益於市場對高性能解決方案和冷媒混合物的強勁需求。

製藥製造業的成長也發揮著重要作用，氯仿被用作提取和純化維生素、生物鹼和抗生素的高效溶劑。尤其是在中國和印度等新興市場，隨著製藥產量的增加以滿足全球醫療需求，高純度溶劑的使用量也不斷增加。根據印度品牌股權基金會 (IBEF) 於 2024 年 7 月發布的《印度製藥業分析》，2024 年 6 月印度製藥市場成長了 8.8%，凸顯了需要溶劑投入的工業活動的成長。這一成長動能也反映在整個氯鹼產業，奧林公司 (Olin Corporation) 在 2025 年發布的報告顯示，其氯鹼產品和乙烯基部門的銷售額在 2024 年第四季度環比成長了 9%，表明包括氯仿在內的氯衍生物的工業需求正在復甦。

市場挑戰

全球氯仿市場的主要障礙在於其環境安全和毒性方面的嚴格法規結構。氯仿被列為疑似致癌性，導致各國制定了嚴格的暴露限值；同時， 《蒙特婁議定書》下的國際義務也在積極推動臭氧消耗物質的逐步淘汰。這些監管壓力直接限制了市場，例如對氯仿的關鍵原料氫氟烴塑膠-22 (HCFC-22) 實施生產配額。因此，製造商被迫在允許應用範圍縮小和合規成本增加的環境下運營，這系統性地抑制了生產擴充性，並阻礙了對擴大產能的投資。

近期工業生產數據從數量上印證了這種限制性的商業環境。根據美國化學工業協會（ACC）預測，2024年美國基礎化學品產量將下降1.5%。這項降幅凸顯了監管挑戰對整個氯鹼及中間體產業造成的實質影響。由於生產商需要應對累積的環境義務，該行業正面臨被迫放緩的生產，儘管上游原料供應穩定，但氯仿價值鏈的成長勢頭卻因此停滯不前。

市場趨勢

全球產能正在發生結構性轉移，並向亞太地區集中，尤其是印度和中國，這兩個國家是工業級氯仿的主要出口中心。這項重組的驅動力在於該地區強大的工業基礎以及當地氯鹼設施為滿足全球需求而進行的戰略性擴張，這些擴張有效地取代了歐洲和北美的老舊設施。印度氯鹼產業業務的成長是這項供應鏈轉移的一個明顯徵兆。根據古吉拉特邦鹼業和化學品有限公司於2024年8月發布的《2023-24年度古吉拉突邦》，該會計年度總產量達到2,046,173公噸，較去年同期成長12.88%。產量的顯著成長印證了亞太地區製造商不斷擴大其在全球市場佔有率的趨勢。

同時，受製藥和科學研發擴張的推動，氘代氯仿作為核磁共振（NMR）波譜分析中高品質溶劑的應用日益成長。隨著藥物研發中複雜有機分子的結構分析和品管變得愈發重要，高純度同位素溶劑的需求也不斷擴大。實驗室規模化學研究的這一發展勢頭也體現在領先的生命科學供應商的財務表現中。默克集團（Merck KGaA）於2024年11月發布的2024年第三季財報顯示，其生命科學業務年增2.1%至22.1億歐元，主要得益於科學與實驗室解決方案業務的復甦。這項商業性成長凸顯了包括氘代氯仿在內的先進分析試劑在支援全球科研基礎設施方面日益成長的重要性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球氯仿市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 等級分類（技術級、醇穩定級、氟化級）
    • 依最終用戶（建築、農業、運輸、醫療、化學、製造、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美氯仿市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲氯仿市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區氯仿市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲氯仿市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲氯仿市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球氯仿市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medical Isotopes, Inc.
  • MP Biomedicals, LLC
  • Oxford Lab Fine Chem LLP
  • Alpha Chemika
  • Arihant Chemical
  • Solvay SA
  • Tokuyama Corporation
  • Shin-Etsu Chemical Co., Ltd.
  • Occidental Petroleum Corporation
  • Merck KGaA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25415

The Global Chloroform Market is projected to expand from 1,048.62 Thousand Tonnes in 2025 to 1,235.42 Thousand Tonnes by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 2.77%. Chloroform, chemically known as trichloromethane, is a volatile, dense, and colorless liquid organic compound primarily used as a solvent and a critical precursor in the creation of fluoropolymers and refrigerants. The market's growth is fundamentally anchored by strong industrial demand for fluoropolymers like polytetrafluoroethylene (PTFE), which are vital for high-performance applications within the electronics and automotive sectors. Additionally, the continued necessity for chloroform as a feedstock in producing hydrochlorofluorocarbon-22 (HCFC-22), particularly for non-emissive feedstock purposes, sustains production levels.

Market Overview
Forecast Period2027-2031
Market Size 20251,048.62 Thousand Tonnes
Market Size 20311,235.42 Thousand Tonnes
CAGR 2026-20312.77%
Fastest Growing SegmentTechnical Grade
Largest MarketAsia Pacific

According to Euro Chlor, total chlorine production by its members hit 8,041 kilotonnes in 2024, providing the essential feedstock for the chloromethanes value chain, which includes chloroform. Although upstream supply remains stable, the market faces significant obstacles due to strict environmental regulations and health concerns associated with the chemical's potential carcinogenicity and toxicity. These regulatory constraints, combined with global mandates from the Montreal Protocol aimed at phasing out ozone-depleting substances, pose a considerable challenge that may limit future market growth.

Market Driver

The primary force driving the Global Chloroform Market is the escalating demand for fluoropolymers, especially polytetrafluoroethylene (PTFE), which heavily depends on chloroform as a key feedstock. Chloroform is processed into hydrochlorofluorocarbon-22 (HCFC-22), the essential monomer for synthesizing high-performance fluoropolymers used widely in the construction, electronics, and automotive industries due to their superior thermal stability and chemical resistance. This demand is further boosted by the shift toward refrigerants with lower global warming potential (GWP) and specialized blends that utilize chloroform derivatives as crucial intermediates. This upward trend is evidenced by The Chemours Company's 'Fourth Quarter and Full Year 2024 Results' from February 2025, which noted that the Thermal & Specialized Solutions segment saw a 7% volume increase in the fourth quarter of 2024, largely driven by robust demand for performance solutions and refrigerant blends.

The growth of the pharmaceutical manufacturing sector also plays a significant role, employing chloroform as a highly effective solvent for extracting and purifying vitamins, alkaloids, and antibiotics. As drug production rises to meet global healthcare needs, especially in emerging markets like China and India, the use of high-purity solvent grades has intensified. The India Brand Equity Foundation (IBEF) reported in its 'Indian Pharmaceutical Industry Analysis' from July 2024 that the Indian pharmaceutical market grew by 8.8% in June 2024, highlighting increased industrial activity requiring solvent inputs. This momentum is mirrored in the broader chlor-alkali chain, with Olin Corporation reporting in 2025 that sales in their Chlor Alkali Products and Vinyls segment rose by 9% sequentially in the fourth quarter of 2024, signaling a recovery in industrial demand for chlorine derivatives, including chloroform.

Market Challenge

The major obstacle hindering the Global Chloroform Market is the rigid regulatory framework regarding environmental safety and toxicity. Chloroform's classification as a probable carcinogen has led to strict exposure limits, while international mandates under the Montreal Protocol actively seek to phase out ozone-depleting substances. These regulatory pressures directly restrict the market by imposing quotas on the production of hydrochlorofluorocarbon-22 (HCFC-22), for which chloroform is a vital feedstock. Consequently, manufacturers must navigate a landscape of reduced permissible applications and rising compliance costs, which systematically curbs production scalability and discourages investment in capacity expansion.

This restrictive operating environment is quantitatively demonstrated by recent industrial output data. According to the American Chemistry Council, production volumes for basic chemicals in the United States fell by 1.5% in 2024. This decline illustrates the tangible effect of regulatory challenges on the broader chlor-alkali and intermediates sector. As producers manage these accumulating environmental obligations, the industry experiences a forced slowdown in output, effectively stalling the growth momentum of the chloroform value chain despite the stability of upstream material availability.

Market Trends

Global production capacities are structurally shifting and consolidating in the Asia-Pacific region, particularly in India and China, positioning these nations as the main export hubs for technical-grade chloroform. This realignment is fueled by the region's strong industrial base and the strategic growth of local chlor-alkali facilities to satisfy global demand, effectively replacing older capacity in Western regions. A clear sign of this supply chain transition is the rising operational output in the Indian sector; Gujarat Alkalies and Chemicals Limited's 'Annual Report 2023-24' from August 2024 reported a 12.88% increase in total production volume to 2,046,173 metric tonnes for the fiscal year. This significant rise in output confirms the trend of Asia-Pacific manufacturers securing a larger portion of the global market.

Simultaneously, there is a growing trend toward using deuterated chloroform as a premium solvent in Nuclear Magnetic Resonance (NMR) spectroscopy, driven by increasing pharmaceutical and academic R&D efforts. As structural analysis and quality control of complex organic molecules become critical in drug discovery, the consumption of high-purity isotopic solvents is expanding. This momentum in laboratory-scale chemical research is reflected in the financial results of major life science suppliers; Merck KGaA's 'Quarterly Statement Q3 2024' from November 2024 showed a 2.1% organic sales increase in the Life Science sector to €2,210 million, led by a recovery in Science & Lab Solutions. This commercial growth highlights the rising importance of advanced analytical reagents, including deuterated chloroform, in supporting global research infrastructure.

Key Market Players

  • Medical Isotopes, Inc.
  • MP Biomedicals, LLC
  • Oxford Lab Fine Chem LLP
  • Alpha Chemika
  • Arihant Chemical
  • Solvay S.A.
  • Tokuyama Corporation
  • Shin-Etsu Chemical Co., Ltd.
  • Occidental Petroleum Corporation
  • Merck KGaA

Report Scope

In this report, the Global Chloroform Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chloroform Market, By Grade

  • Technical Grade
  • Alcohol Stabilized Grade
  • Fluorocarbon Grade

Chloroform Market, By End User

  • Construction
  • Agriculture
  • Transportation
  • Healthcare
  • Chemical
  • Industrial
  • Others

Chloroform Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chloroform Market.

Available Customizations:

Global Chloroform Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chloroform Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Grade (Technical Grade, Alcohol Stabilized Grade, Fluorocarbon Grade)
    • 5.2.2. By End User (Construction, Agriculture, Transportation, Healthcare, Chemical, Industrial, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Chloroform Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Grade
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chloroform Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Grade
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Chloroform Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Grade
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Chloroform Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Grade
        • 6.3.3.2.2. By End User

7. Europe Chloroform Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Grade
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chloroform Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Grade
        • 7.3.1.2.2. By End User
    • 7.3.2. France Chloroform Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Grade
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Chloroform Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Grade
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Chloroform Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Grade
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Chloroform Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Grade
        • 7.3.5.2.2. By End User

8. Asia Pacific Chloroform Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Grade
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chloroform Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Grade
        • 8.3.1.2.2. By End User
    • 8.3.2. India Chloroform Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Grade
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Chloroform Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Grade
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Chloroform Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Grade
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Chloroform Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Grade
        • 8.3.5.2.2. By End User

9. Middle East & Africa Chloroform Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Grade
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chloroform Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Grade
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Chloroform Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Grade
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Chloroform Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Grade
        • 9.3.3.2.2. By End User

10. South America Chloroform Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Grade
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chloroform Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Grade
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Chloroform Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Grade
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Chloroform Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Grade
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chloroform Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medical Isotopes, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. MP Biomedicals, LLC
  • 15.3. Oxford Lab Fine Chem LLP
  • 15.4. Alpha Chemika
  • 15.5. Arihant Chemical
  • 15.6. Solvay S.A.
  • 15.7. Tokuyama Corporation
  • 15.8. Shin-Etsu Chemical Co., Ltd.
  • 15.9. Occidental Petroleum Corporation
  • 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer